phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with Pre-Eclampsia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Klausen, C; Leung, PCK; Li, Y; Peng, B; von Dadelszen, P; Xiong, S; Yi, Y; Zhu, H | 1 |
1 other study(ies) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Pre-Eclampsia
Article | Year |
---|---|
NPFF increases fusogenic proteins syncytin 1 and syncytin 2 via GCM1 in first trimester primary human cytotrophoblast cells.
Topics: Biomarkers; DNA-Binding Proteins; Female; Gene Expression Profiling; Gene Expression Regulation; Gene Products, env; Humans; Narcotic Antagonists; Oligopeptides; Placentation; Pre-Eclampsia; Pregnancy; Pregnancy Proteins; Pregnancy Trimester, First; Receptors, Neuropeptide; Transcription Factors; Trophoblasts | 2020 |